STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia - Université de Bretagne Occidentale Access content directly
Journal Articles Journal for Immunotherapy of Cancer Year : 2019

STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia

Abstract

Dysregulation in calcium (Ca2+) signaling is a hallmark of chronic lymphocytic leukemia (CLL). While the role of the B cell receptor (BCR) Ca2+ pathway has been associated with disease progression, the importance of the newly described constitutive Ca2+ entry (CE) pathway is less clear. In addition, we hypothesized that these differences reflect modifications of the CE pathway and Ca2+ actors such as Orai1, transient receptor potential canonical (TRPC) 1, and stromal interaction molecule 1 (STIM1), the latter being the focus of this study.

Dates and versions

hal-02114358 , version 1 (29-04-2019)

Identifiers

Cite

Marjolaine Debant, Miguel Burgos, Patrice Hémon, Paul Buscaglia, Tinhinane Fali, et al.. STIM1 at the plasma membrane as a new target in progressive chronic lymphocytic leukemia. Journal for Immunotherapy of Cancer, 2019, 7 (1), pp.111. ⟨10.1186/s40425-019-0591-3⟩. ⟨hal-02114358⟩
64 View
0 Download

Altmetric

Share

Gmail Facebook X LinkedIn More